Beijing biotech Sironax has closed a whopping $200 ... development of its RIPK1 inhibitors as well as to expand its pipeline of drug candidates in other classes. RIPK1 – or receptor-interacting ...

Chicago, IL – February 3, 2025 – Today, Zacks Equity Research discusses Corcept Therapeutics CORT, Amneal Pharmaceuticals AMRX, Dyne Therapeutics DYN, Nektar Therapeutics NKTR and Cardiol Therapeutics ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

Roche has given two early-phase bispecifics the heave-ho, ending work on a HER2xCD3 prospect and an IL-15 candidate it picked ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Legend Biotech Corporation (NASDAQ:LEGN), with a market capitalization of $6.74 billion, has emerged as a prominent player in the biotechnology sector, primarily due to the success of its flagship ...

A new report on the UK’s bioscience sector shows it enjoyed a strong 2017, with international investment fuelling pipelines. The UK has reaffirmed itself as one of Europe’s biotech powerhouses ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Evaxion Biotech A/S announced the successful closing ... $10.8 million to advance its AI-Immunology™ powered vaccine pipeline and cover operational costs. The offering was priced at $2.71 ...

CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a ...

I-Mab’s pipeline pivot had a sting in the tail. Weeks after shifting its focus, the biotech said Wednesday that it has reduced its workforce by around 27% in conjunction with the pipeline ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...